The global Patient Temperature Monitoring Market, valued at US$2.31 billion in 2024 stood at US$2.44 billion in 2025 and is ...

The stock's fall snapped a two-day winning streak.

This was the stock's fourth consecutive day of gains.

Solventum (NYSE: SOLV) announced today its executives will participate in a fireside chat at the Goldman Sachs 46th Annual ...

Solventum expects 2028 operating margins of 23%-25% and 10% EPS CAGR. Q4 adjusted EPS of $1.41 beat the consensus of $1.32 on $2.07 billion in sales. 3 Summer "Power Patterns" Are About to Trigger ...

Solventum Logo (PRNewsfoto/3M Healthcare US Opco LLC) "Solventum has tremendous potential, with attractive businesses, large and growing markets, and highly regarded brands. We have undertaken a ...

ST. PAUL, Minn., March 20, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today hosts its 2025 Investor Day and will outline strategic priorities for the Company, its business segments, and its long ...

Feb 27 (Reuters) - 3M spin-off Solventum (SOLV.N), opens new tab forecast annual profit above analyst estimates on Thursday, betting on strong sales of its wound care and surgical sterilization ...

In the final days of November, I was getting slightly concerned about a long position in Solventum Corporation (NYSE:SOLV) after shares had enjoyed a partial re-rating. By now, the healthcare spin ...

Nelson Peltz’s Trian Fund Management plans to push Solventum (SOLV) to separate more of its businesses after the company sold its filtration unit, Ben Glickman of Wall Street Journal reports ...

Shares of Solventum rose Tuesday after the company agreed to sell its filtration and purification business to medical device maker Thermo Fisher Scientific for $4.1 billion. Solventum Chief ...